{"componentChunkName":"component---src-templates-topic-topic-tsx","path":"/topics/hirsutism/","result":{"data":{"firstChapter":{"id":"7f1b7b92-6387-5893-b9c1-1b0fe5e6921f","slug":"summary","fullItemName":"Summary","subChapters":[],"depth":1,"htmlHeader":"<!-- begin field 5682856c-0591-43a7-bcc4-242c6c202f2c --><h1>Hirsutism: Summary</h1><!-- end field 5682856c-0591-43a7-bcc4-242c6c202f2c -->","htmlStringContent":"<!-- begin item 4cfd9c4c-59ed-4384-b576-81ed1a7bdd51 --><!-- begin field e614e96c-4546-4e14-901d-e563fa04c5e1 --><ul><li>Hirsutism is the growth of excess terminal hair in androgen-dependent areas in women (for example face, chest, abdomen, lower back, upper arms, and thighs).</li><li>Hirsutism occurs because of the effect of increased androgens on the pilosebaceous unit (from which the hair shaft appears), increased pilosebaceous unit sensitivity to androgens, or the peripheral metabolism of androgens.<ul><li>Polycystic ovary syndrome (PCOS) is the most common cause of hirsutism (more than 70% of cases). No apparent underlying cause is found in about half of women with mild hirsutism. Androgen secreting tumours, adrenal hyperplasia, Cushing’s syndrome, acromegaly, hyperprolactinaemia, thyroid disorders, and some drugs are less common causes of hirsutism.</li><li>In menopausal women,<strong> </strong>reduction in oestrogen and progesterone production can result in hair and skin disorders. The reduction in progesterone can increase the influence of androgens on the sebaceous glands and hair follicles.  </li></ul></li><li>An underlying cause should be looked for:<ul><li>In women with local, isolated sexual hair growth, a normal hirsutism score, and no other signs of a hyperandrogenic endocrine disorder, investigations are not usually necessary unless hair growth progresses despite treatment.</li><li>In all women with an abnormal hirsutism score, or local sexual hair growth with clinical evidence of a hyperandrogenic endocrine disorder, elevated androgen levels (serum total testosterone level) should be tested for. If the testosterone level is greater than 4 nanomol/L, referral to endocrinology should be arranged.</li></ul></li><li>Management options in primary care for premenopausal women include:<ul><li>Weight loss (if obese or overweight).</li><li>Hair reduction and removal treatments (such as shaving, waxing, electrolysis, or laser treatment).</li><li>Eflornithine cream (for facial hirsutism in women aged 19 years and older).</li><li>A combined oral contraceptive (COC), provided there are no contraindications.</li></ul></li><li>Management options in primary care for postmenopausal women include:<ul><li>Cosmetic hair reduction and removal.</li><li>Eflornithine cream (for facial hirsutism).</li><li>Weight loss (if obese or overweight).</li></ul></li><li>Referral to a specialist is recommended if:<ul><li>There are clinical features suggestive of an underlying adrenal or ovarian neoplasm (urgent referral). Features of androgen-secreting tumours include sudden onset and rapid progression of hair growth, signs of virilization, or an abdominal or pelvic mass.</li><li>Another underlying endocrine condition is suspected that requires secondary care diagnosis and/or management.</li><li>Treatment has not been effective after at least 6 months' trial.</li></ul></li><li>Treatments that may be offered by specialists include:<ul><li>Anti-androgens (such as cyproterone acetate, finasteride, spironolactone, and flutamide).</li><li>Insulin-sensitizing drugs.</li><li>Gonadotrophin-releasing hormone analogues.</li></ul></li></ul><!-- end field e614e96c-4546-4e14-901d-e563fa04c5e1 --><!-- end item 4cfd9c4c-59ed-4384-b576-81ed1a7bdd51 -->","topic":{"id":"f7bb546f-c63b-5f36-8592-742d53a300ba","topicId":"6cd0021b-eeb7-4f76-9627-4f095658d33a","topicName":"Hirsutism","slug":"hirsutism","aliases":[],"chapters":[{"id":"7f1b7b92-6387-5893-b9c1-1b0fe5e6921f","slug":"summary","fullItemName":"Summary","subChapters":[]},{"id":"ad41ddff-180c-5c56-9fa8-cfcaa4b301ac","slug":"have-i-got-the-right-topic","fullItemName":"Have I got the right topic?","subChapters":[]},{"id":"4e6e27c3-ace8-5785-bc5d-74954333ce03","slug":"how-up-to-date-is-this-topic","fullItemName":"How up-to-date is this topic?","subChapters":[{"id":"84d0d634-74f6-5808-8f94-da5030ec05c6","slug":"changes","fullItemName":"Changes"},{"id":"24cd5147-9eea-5049-abb9-bbff6b2e15e8","slug":"update","fullItemName":"Update"}]},{"id":"bccddc08-eaf5-58bc-b91c-222a0631380a","slug":"goals-outcome-measures","fullItemName":"Goals and outcome measures","subChapters":[{"id":"d59efd74-c7e8-5a58-88a9-274b74de9cc7","slug":"goals","fullItemName":"Goals"},{"id":"3e4b60ae-49dd-58fa-8977-9a8f93804089","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"fb5d6918-d9cd-57de-8ef8-09ac15afb519","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"fb74a918-ba53-56c2-b640-6a8b38dd4d52","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"0a97044d-161a-536d-99bd-e30a0b9553dd","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"ed166746-cb44-593f-aa91-2daa54e9df51","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"530429b5-0393-529c-874a-7270e7bccb64","slug":"background-information","fullItemName":"Background information","subChapters":[{"id":"2c5b6cec-8e35-5953-a425-773d40af6f62","slug":"definition","fullItemName":"Definition"},{"id":"7c04b952-69e3-54ba-abf5-964402df757c","slug":"causes","fullItemName":"Causes"},{"id":"1ab4046f-c4e7-520f-893f-e09d2db4390d","slug":"prevalence","fullItemName":"Prevalence"},{"id":"dce06012-6849-5ef4-ab2b-0c84dc64de89","slug":"complications","fullItemName":"Complications"}]},{"id":"0e4a9c3d-b4db-57a6-b036-9e01073ecafc","slug":"diagnosis","fullItemName":"Diagnosis","subChapters":[{"id":"a58667b3-2a20-5be2-81aa-4b35ba1bc423","slug":"diagnosis","fullItemName":"Diagnosis"},{"id":"fc818766-2cdb-52a0-ad0e-7925d2deab29","slug":"assessment-for-an-underlying-cause","fullItemName":"Assessment for an underlying cause"},{"id":"3e40d667-a42d-56c7-a222-6eb858be7c6d","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"684a1492-2308-5cae-b75d-1460cf238959","slug":"management","fullItemName":"Management","subChapters":[{"id":"eb3e5264-aa93-5618-a326-1f9052e41577","slug":"management","fullItemName":"Scenario: Management"}]},{"id":"61f39625-be0c-52a3-bdb4-7f1b9eaf0ffd","slug":"prescribing-information","fullItemName":"Prescribing information","subChapters":[{"id":"4573c138-4cd9-557f-9ff3-297c6187958a","slug":"topical-eflornithine","fullItemName":"Topical eflornithine"}]},{"id":"1d2fa7d5-926c-5ced-b5ff-0c103d1ddbbc","slug":"supporting-evidence","fullItemName":"Supporting evidence","subChapters":[]},{"id":"3154c9fd-0eb5-5ee3-8a69-a18ed1a66193","slug":"how-this-topic-was-developed","fullItemName":"How this topic was developed","subChapters":[{"id":"243b8cac-0f37-5266-bf46-8279e00461db","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"5fab04c2-7dc7-5ebd-89cd-f693a3cd663f","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"b5b1cd8e-118a-5aab-bc89-4fa265c0b038","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"d0d01f8a-60fc-5ef2-94a6-9d894ebe74d4","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"74f5177a-4053-5623-b286-63a07a583386","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"34dca8b6-44ff-5ef5-8816-48aa07f93aff","slug":"references","fullItemName":"References","subChapters":[]}]}},"topic":{"id":"f7bb546f-c63b-5f36-8592-742d53a300ba","topicId":"6cd0021b-eeb7-4f76-9627-4f095658d33a","topicName":"Hirsutism","slug":"hirsutism","aliases":[],"topicSummary":"Hirsutism is the growth of excess terminal hair on the face, chest, linea alba, lower back, buttocks, and anterior thighs in women.","lastRevised":"Last revised in July 2020","nextPlannedReviewBy":"2025-01-01T00:00:00+00:00","nextPlannedReviewByDateTime":"2025-01","nextPlannedReviewByDisplay":"January 2025","specialities":[{"id":"50071c38-ab10-5ab8-ac70-6bd19a96c24e","name":"Skin and nail","slug":"skin-nail"},{"id":"0c813417-9691-5826-9371-c4bec6c53f06","name":"Women's health","slug":"womens-health"}],"chapters":[{"id":"7f1b7b92-6387-5893-b9c1-1b0fe5e6921f","slug":"summary","fullItemName":"Summary","subChapters":[]},{"id":"ad41ddff-180c-5c56-9fa8-cfcaa4b301ac","slug":"have-i-got-the-right-topic","fullItemName":"Have I got the right topic?","subChapters":[]},{"id":"4e6e27c3-ace8-5785-bc5d-74954333ce03","slug":"how-up-to-date-is-this-topic","fullItemName":"How up-to-date is this topic?","subChapters":[{"id":"84d0d634-74f6-5808-8f94-da5030ec05c6","slug":"changes","fullItemName":"Changes"},{"id":"24cd5147-9eea-5049-abb9-bbff6b2e15e8","slug":"update","fullItemName":"Update"}]},{"id":"bccddc08-eaf5-58bc-b91c-222a0631380a","slug":"goals-outcome-measures","fullItemName":"Goals and outcome measures","subChapters":[{"id":"d59efd74-c7e8-5a58-88a9-274b74de9cc7","slug":"goals","fullItemName":"Goals"},{"id":"3e4b60ae-49dd-58fa-8977-9a8f93804089","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"fb5d6918-d9cd-57de-8ef8-09ac15afb519","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"fb74a918-ba53-56c2-b640-6a8b38dd4d52","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"0a97044d-161a-536d-99bd-e30a0b9553dd","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"ed166746-cb44-593f-aa91-2daa54e9df51","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"530429b5-0393-529c-874a-7270e7bccb64","slug":"background-information","fullItemName":"Background information","subChapters":[{"id":"2c5b6cec-8e35-5953-a425-773d40af6f62","slug":"definition","fullItemName":"Definition"},{"id":"7c04b952-69e3-54ba-abf5-964402df757c","slug":"causes","fullItemName":"Causes"},{"id":"1ab4046f-c4e7-520f-893f-e09d2db4390d","slug":"prevalence","fullItemName":"Prevalence"},{"id":"dce06012-6849-5ef4-ab2b-0c84dc64de89","slug":"complications","fullItemName":"Complications"}]},{"id":"0e4a9c3d-b4db-57a6-b036-9e01073ecafc","slug":"diagnosis","fullItemName":"Diagnosis","subChapters":[{"id":"a58667b3-2a20-5be2-81aa-4b35ba1bc423","slug":"diagnosis","fullItemName":"Diagnosis"},{"id":"fc818766-2cdb-52a0-ad0e-7925d2deab29","slug":"assessment-for-an-underlying-cause","fullItemName":"Assessment for an underlying cause"},{"id":"3e40d667-a42d-56c7-a222-6eb858be7c6d","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"684a1492-2308-5cae-b75d-1460cf238959","slug":"management","fullItemName":"Management","subChapters":[{"id":"eb3e5264-aa93-5618-a326-1f9052e41577","slug":"management","fullItemName":"Scenario: Management"}]},{"id":"61f39625-be0c-52a3-bdb4-7f1b9eaf0ffd","slug":"prescribing-information","fullItemName":"Prescribing information","subChapters":[{"id":"4573c138-4cd9-557f-9ff3-297c6187958a","slug":"topical-eflornithine","fullItemName":"Topical eflornithine"}]},{"id":"1d2fa7d5-926c-5ced-b5ff-0c103d1ddbbc","slug":"supporting-evidence","fullItemName":"Supporting evidence","subChapters":[]},{"id":"3154c9fd-0eb5-5ee3-8a69-a18ed1a66193","slug":"how-this-topic-was-developed","fullItemName":"How this topic was developed","subChapters":[{"id":"243b8cac-0f37-5266-bf46-8279e00461db","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"5fab04c2-7dc7-5ebd-89cd-f693a3cd663f","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"b5b1cd8e-118a-5aab-bc89-4fa265c0b038","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"d0d01f8a-60fc-5ef2-94a6-9d894ebe74d4","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"74f5177a-4053-5623-b286-63a07a583386","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"34dca8b6-44ff-5ef5-8816-48aa07f93aff","slug":"references","fullItemName":"References","subChapters":[]}]}},"pageContext":{"id":"f7bb546f-c63b-5f36-8592-742d53a300ba"}},"staticQueryHashes":["3666801979"]}